Topic
Infant Formula
386 published works
Marler Blog
FDA’s ByHeart Inspection Report Is Finally Public — and It Points at the Milk — But Everyone Still Owns the Bottle
By Bill Marler
On Thursday, June 11, 2026, the FDA quietly posted to its website the document those of us investigating the ByHeart infant-botulism outbreak have waited months to see: the complete Establishment…
Marler Blog
Forty-Eight Babies with Botulism, Seventeen States, and a “Focus on Ingredients”
By Bill Marler
The FDA yesterday quietly put up a new page describing its “post-outbreak response activities” for the Clostridium botulinum illnesses tied to ByHeart powdered infant formula. I have read it more than once.…
Marler Blog
In the Botulism Outbreak, the One Name the FDA Decided You Shouldn’t See
By Bill Marler
I have spent more than thirty years representing the people who get left holding the bill for someone else’s contaminated food. I have read more outbreak reports than I can…
The Daily Intake
FDA Issues Final Guidance on Protein Efficiency Ratio (PER) Studies for Infant Formula
On May 21, 2026, FDA issued a final guidance for Industry: "Protein Efficiency Ratio (PER) Rat Bioassay Studies to Demonstrate That a New Infant Formula Supports the Quality Factor of…
Marler Blog
The infant formula industry was warned about Botulism long before an Outbreak
By Bill Marler
“Historical associations between powdered infant formula and pathogens such as Cronobacter spp., Salmonella, and Clostridium botulinum should be considered when designing and implementing controls for the safe manufacture of all foods for infants and young…
Marler Blog
Bacillus cereus toxin, Cereulide, prompts another infant formula recall
By Bill Marler
The a2 Milk Company (“a2MC”) has voluntarily recalled three specific batches of its imported a2 Platinum Premium USA label infant formula 0-12 months (“Product”) due to the presence of cereulide.…
The Daily Intake
FDA Infant Formula Testing Confirms Safety of U.S. Supply
On April 29, 2026, the U.S. Food and Drug Administration (FDA) announced the results of the largest and most comprehensive testing program ever conducted on infant formula sold in the…
Marler Blog
ByHeart Botulism Infant Formula Cases consolidated in New York Federal Court
By Bill Marler
UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION IN RE: BYHEART, INC., INFANT FORMULA MARKETING, SALES PRACTICES, AND PRODUCTS LIABILITY LITIGATION MDL No. 3178 TRANSFER ORDER Before the Panel: Plaintiffs in…
Marler Blog
To Safer Infant Formulas and doing away with Botulism, Cronobacter sakazakii, Salmonella and Bacillus cereus
By Bill Marler
A bit over a month ago, I was set to testify before the House and Senate Safe Food Caucus in D.C.. Instead, the night before I had a heart attack.…
Marler Blog
South Carolina warns Botulism Contaminated Infant Formula Still on Market
By Bill Marler
Potentially Contaminated Infant Formula Still on Market S.C. Department of Agriculture Urges Businesses, Food Banks to Check Facilities for Recalled ByHeart Product COLUMBIA – Following notice from the U.S. Food…